Mycotoxin Testing Market by Offering Type, Testing Technique, Toxin Type, Sample Type, Testing Setting, Automation Level, Sourcing Model, End Use

List of Tables

The Mycotoxin Testing Market is projected to grow by USD 4.93 billion at a CAGR of 7.93% by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 2.88 billion
Estimated Year [2026]	USD 3.09 billion
Forecast Year [2032]	USD 4.93 billion
CAGR (%)	7.93%

Mycotoxin testing is a critical food safety, feed safety, and trade assurance function because toxins such as aflatoxins, ochratoxin A, fumonisins, deoxynivalenol, zearalenone, T-2/HT-2 toxins, and patulin can enter supply chains through cereals, oilseeds, nuts, dried fruits, spices, coffee, milk, and animal feed. The World Health Organization identifies mycotoxins as naturally occurring toxic compounds produced by molds, while Codex Alimentarius, the U.S. FDA, and the European Commission set or reference limits for key commodities to protect consumers and support fair trade.

Demand for reliable mycotoxin analysis is rising as global sourcing, climate variability, and stricter import controls increase the need for validated screening and confirmatory methods. Laboratories and manufacturers are prioritizing LC-MS/MS, HPLC, ELISA, lateral flow assays, immunoaffinity cleanup, representative sampling, and accredited quality systems to reduce recalls, protect consumers, and maintain market access.

Transformative Shifts in the Mycotoxin Testing Landscape

The mycotoxin testing landscape is shifting from reactive batch testing toward preventive, risk-based surveillance across farms, storage, processing, and import checkpoints. Climate-linked changes in temperature, rainfall, drought stress, and pest pressure are influencing fungal growth patterns, making historical contamination maps less reliable for commodities such as maize, wheat, peanuts, tree nuts, dried fruits, coffee, and spices.

Regulatory convergence is also reshaping testing priorities. The European Union's contaminant framework, U.S. FDA action levels, Codex guidance, and national feed rules are pushing food businesses to document sampling plans, validated analytical methods, traceable records, and corrective actions. At the same time, buyers increasingly require multi-mycotoxin panels because co-occurrence is common in grains and feed ingredients, especially when weather and storage conditions favor multiple fungal species.

Cumulative Impact of Artificial Intelligence on Mycotoxin Testing

Artificial intelligence is beginning to compound the value of mycotoxin testing by connecting weather data, crop phenology, storage conditions, historical test results, and supplier performance into predictive risk models. Instead of relying only on end-product testing, AI-enabled systems can help identify high-risk lots, optimize sampling intensity, and prioritize confirmatory analysis where the probability of contamination is highest.

In laboratories, machine learning can support chromatographic peak review, spectral interpretation, anomaly detection, and LIMS-driven workflow optimization. AI does not replace validated analytical chemistry, representative sampling, or regulatory decision-making, but it can reduce turnaround time, improve consistency, and help quality teams convert fragmented test records into early-warning intelligence for aflatoxin, deoxynivalenol, fumonisin, ochratoxin A, and zearalenone control.

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Asia-Pacific is a high-priority region because rice, maize, wheat, peanuts, spices, and feed ingredients move through complex domestic and export supply chains. China, India, Japan, South Korea, Australia, and ASEAN markets are strengthening surveillance as food safety modernization, export compliance, and import inspection programs expand. North America remains defined by advanced laboratory infrastructure, U.S. FDA action levels, USDA grain inspection practices, Canadian grain quality systems, and strong testing demand from grain, dairy, pet food, and feed sectors.

Latin America is central to global mycotoxin testing because Brazil, Mexico, and other agricultural exporters supply maize, soy, peanuts, coffee, and animal feed ingredients to international markets. Europe maintains one of the most rigorous compliance environments through harmonized contaminant rules, routine monitoring, accredited laboratories, and frequent border controls for high-risk foods. The Middle East relies heavily on imported cereals, nuts, spices, and feed, increasing demand for port-of-entry testing and conformity assessment, while Africa faces significant public health and food security concerns from aflatoxin exposure in maize and groundnuts, making affordable rapid testing, sampling training, and laboratory capacity building essential.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN countries are expanding food export certification and import monitoring for rice, spices, feed ingredients, and processed foods, with mycotoxin testing increasingly embedded in HACCP, supplier approval, and border inspection programs. The GCC is import-dependent for cereals, nuts, spices, and animal feed, making rapid port testing, conformity assessment, and traceable documentation important for food security and regulatory confidence.

The European Union influences global benchmarks through legally enforceable maximum levels, coordinated monitoring, and high demand for accredited testing. BRICS economies combine major agricultural production, large consumer markets, and growing laboratory capacity, creating broad demand for rapid screening and confirmatory methods across grains, oilseeds, nuts, spices, dairy-linked feed chains, and animal protein supply chains. G7 countries emphasize advanced instrumentation, traceability, risk-based regulation, and consumer protection, while NATO member markets often overlap with stringent food defense, logistics resilience, and public procurement requirements that reinforce verified food and feed safety controls.

Key Country Insights Across Major Mycotoxin Testing Markets

In the United States, mycotoxin testing is driven by FDA action levels, grain merchandising standards, pet food safety, dairy aflatoxin M1 controls, and export documentation. Canada emphasizes grain quality, feed safety, and science-based surveillance, while Mexico's maize, peanut, and feed supply chains require reliable aflatoxin and fumonisin monitoring. Brazil's role in soy, maize, peanuts, coffee, and animal protein exports makes testing central to trade assurance and buyer compliance.

The United Kingdom, Germany, France, Italy, and Spain operate within strict European food safety expectations, supported by accredited laboratories and routine monitoring of cereals, nuts, dried fruits, wine, coffee, and feed. Russia's grain and feed markets require contamination control for domestic consumption and export channels. China and India face large-scale testing needs across grains, oilseeds, spices, nuts, and dairy-linked feed chains; Japan and South Korea emphasize import compliance, high-quality analytical standards, and strong consumer protection; Australia focuses on grain export integrity, feed safety, and risk management in drought-affected production systems.

Actionable Recommendations for Mycotoxin Testing Industry Leaders

Industry leaders should build risk-based mycotoxin programs that combine supplier qualification, representative sampling, rapid screening, confirmatory LC-MS/MS testing, and documented corrective actions. Testing strategies should reflect commodity risk, geography, seasonality, crop stress, storage conditions, intended use, and regulatory destination rather than applying a one-size-fits-all protocol.

Companies should invest in ISO/IEC 17025-aligned laboratory partnerships, validated multi-mycotoxin panels, digital chain-of-custody, proficiency testing, and AI-assisted risk forecasting. Feed manufacturers, grain handlers, food processors, exporters, and importers should also integrate moisture control, storage monitoring, segregation, supplier audits, and detoxification policies where legally permitted to reduce contamination before it becomes a market access or consumer safety issue.

Research Methodology for Mycotoxin Testing Insights

This executive summary is grounded in secondary research from recognized public authorities and standards bodies, including WHO, FAO, Codex Alimentarius, the U.S. FDA, USDA resources, the European Commission, EFSA communications, and national food safety agencies. The analysis considers established mycotoxin categories, regulated commodities, sampling principles, laboratory methods, public health risks, and documented compliance requirements.

Market interpretation was developed through triangulation of regulatory frameworks, commodity trade patterns, laboratory technology adoption, climate-related contamination drivers, and food safety compliance trends. The methodology prioritizes verified facts, avoids unsupported market sizing, and focuses on evidence-based implications for testing providers, food and feed manufacturers, exporters, importers, and quality assurance leaders.

Conclusion: Mycotoxin Testing as a Strategic Food Safety Priority

Mycotoxin testing is becoming a strategic requirement for food safety, animal health, regulatory compliance, and global trade resilience. The combined pressure of climate variability, complex sourcing, tighter contaminant limits, and consumer safety expectations is increasing the need for faster, broader, and more defensible testing programs.

Organizations that integrate validated analytical methods, predictive risk intelligence, accredited laboratory practices, representative sampling, and proactive supplier controls will be better positioned to reduce recalls, protect brand trust, and maintain access to regulated markets. The strongest opportunities will favor testing ecosystems that deliver accuracy, speed, traceability, and actionable risk prevention without compromising scientific validity or regulatory confidence.

Product Code: MRR-43676CF42908

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Mycotoxin Testing Market, by Offering Type

7.1. Instruments
7.2. Sample Preparation Consumables
7.3. Software & Informatics
7.4. Services

8. Mycotoxin Testing Market, by Testing Technique

8.1. Enzyme Linked Immunosorbent Assay
8.2. High Performance Liquid Chromatography
8.3. Liquid Chromatography Mass Spectrometry
8.4. Polymerase Chain Reaction
8.5. Rapid Test Kits

9. Mycotoxin Testing Market, by Toxin Type

9.1. Aflatoxin
9.2. Fumonisin
9.3. Ochratoxin
9.4. Trichothecenes
9.5. Zearalenone

10. Mycotoxin Testing Market, by Sample Type

10.1. Cereals & Grains
- 10.1.1. Barley
- 10.1.2. Maize
- 10.1.3. Oats
- 10.1.4. Rice
- 10.1.5. Wheat
10.2. Dairy Products
10.3. Fruits & Vegetables
- 10.3.1. Apples
- 10.3.2. Grapes
- 10.3.3. Tomatoes
10.4. Nuts & Seeds
- 10.4.1. Almonds
- 10.4.2. Peanuts
- 10.4.3. Walnuts
10.5. Spices & Herbs
- 10.5.1. Cinnamon
- 10.5.2. Pepper
- 10.5.3. Turmeric

11. Mycotoxin Testing Market, by Testing Setting

11.1. On-Site
11.2. Near-Site

12. Mycotoxin Testing Market, by Automation Level

12.1. Manual
12.2. Semi-Automated
12.3. Fully Automated

13. Mycotoxin Testing Market, by Sourcing Model

13.1. In-House
13.2. Outsourced
13.3. Hybrid

14. Mycotoxin Testing Market, by End Use

14.1. Animal Feed
- 14.1.1. Compound Feed
- 14.1.2. Feed Mills
14.2. Environmental Testing
- 14.2.1. Soil Testing
- 14.2.2. Water Testing
14.3. Food & Beverage
- 14.3.1. Bakery
- 14.3.2. Beverages
- 14.3.3. Dairy Processing
14.4. Pharmaceutical
- 14.4.1. Drug Formulation
- 14.4.2. Quality Control

15. Mycotoxin Testing Market, by Region

15.1. Asia-Pacific
15.2. North America
15.3. Latin America
15.4. Europe
15.5. Middle East
15.6. Africa

16. Mycotoxin Testing Market, by Group

16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO

17. Mycotoxin Testing Market, by Country

17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
- 18.1.1. Concentration Ratio (CR)
- 18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025

19. Company Profiles

19.1. AES Laboratories Pvt. Ltd.
19.2. Agilent Technologies, Inc.
19.3. ALS Limited
19.4. AsureQuality Limited
19.5. Bio-Check Ltd.
19.6. Biotage AB
19.7. Bruker Corporation
19.8. Bureau Veritas SA
19.9. Charm Sciences Inc.
19.10. EnviroLogix Inc.
19.11. Eurofins Scientific SE
19.12. Fera Science Ltd.
19.13. IEH Laboratories & Consulting Group
19.14. Intertek Group plc
19.15. LGC Limited
19.16. Merck KGaA
19.17. Microbac Laboratories Inc.
19.18. Merieux NutriSciences Corporation
19.19. Neogen Corporation
19.20. ProGnosis Biotech S.A.
19.21. R J Hill Laboratories Limited
19.22. R-Biopharm AG
19.23. Randox Food Diagnostics
19.24. Romer Labs
19.25. Romer Labs Division Holding GmbH
19.26. SGS SA
19.27. Shimadzu Corporation
19.28. Symbio Laboratories
19.29. Thermo Fisher Scientific Inc.
19.30. Trilogy Analytical Laboratory, Inc.
19.31. Waters Corporation
19.32. ZEULAB S.L.